HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshinori Makino Selected Research

Cell Transplantation

10/2020Nausea and vomiting during post-transplantation cyclophosphamide administration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshinori Makino Research Topics

Disease

11Neoplasms (Cancer)
03/2019 - 06/2007
5Lung Neoplasms (Lung Cancer)
04/2022 - 04/2012
4Nausea
04/2021 - 01/2018
4Vomiting
04/2021 - 01/2018
3Neutropenia
11/2019 - 04/2012
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 10/2015
2Stomach Neoplasms (Stomach Cancer)
04/2020 - 01/2012
2Hand-Foot Syndrome
07/2018 - 01/2012
2Ovarian Neoplasms (Ovarian Cancer)
07/2018 - 10/2016
2Infections
01/2010 - 06/2008
1Male Infertility (Male Sterility)
01/2022
1Hypertension (High Blood Pressure)
04/2021
1Atrioventricular Block
04/2021
1Graft vs Host Disease (Graft-Versus-Host Disease)
10/2020
1Peripheral Nervous System Diseases (PNS Diseases)
04/2020
1Necrosis
12/2018
1Stomatitis
07/2018
1Hypersensitivity (Allergy)
07/2018
1Hemorrhagic Cystitis
09/2016
1Leiomyosarcoma
06/2016
1Pathologic Processes
07/2015
1Body Weight (Weight, Body)
12/2012
1Breast Neoplasms (Breast Cancer)
01/2012
1Synovial Sarcoma (Synovioma)
07/2006
1Sarcoma (Soft Tissue Sarcoma)
07/2006
1Poliomyelitis (Polio)
12/2004
1Malignant Mesothelioma
12/2004

Drug/Important Bio-Agent (IBA)

5Pharmaceutical PreparationsIBA
04/2021 - 10/2015
5amrubicinIBA
11/2019 - 03/2010
4amrubicinolIBA
11/2019 - 03/2010
3Aprepitant (Emend)FDA Link
04/2022 - 03/2019
3Cisplatin (Platino)FDA LinkGeneric
04/2022 - 01/2018
3Proteins (Proteins, Gene)FDA Link
06/2007 - 12/2004
2Dexamethasone (Maxidex)FDA LinkGeneric
04/2022 - 10/2020
2Paclitaxel (Taxol)FDA LinkGeneric
04/2020 - 10/2016
2PlatinumIBA
04/2020 - 11/2019
2IfosfamideFDA LinkGeneric
01/2018 - 09/2016
1Cytochrome P-450 CYP3AIBA
04/2022
1AntiemeticsIBA
04/2022
1EnzymesIBA
04/2022
1Retroelements (Retrotransposon)IBA
01/2022
1ErbB Receptors (EGF Receptor)IBA
04/2021
1GemcitabineFDA Link
04/2021
1Monoclonal AntibodiesIBA
04/2021
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
04/2021
1Investigational DrugsIBA
04/2021
1Amlodipine (Norvasc)FDA LinkGeneric
04/2021
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2020
1Adrenal Cortex Hormones (Corticosteroids)IBA
10/2020
1RamucirumabIBA
04/2020
1Neurokinin-1 Receptor AntagonistsIBA
03/2019
1fosaprepitantFDA Link
03/2019
1Oxygen (Dioxygen)IBA
12/2018
11-dodecylpyridoxal (PLD)IBA
07/2018
1liposomal doxorubicin (Doxil)FDA Link
07/2018
1Olanzapine (Zyprexa)FDA Link
01/2018
1Antipsychotic Agents (Antipsychotics)IBA
01/2018
1Carboplatin (JM8)FDA LinkGeneric
10/2016
1pazopanibFDA Link
06/2016
1tegafur-gimeracil-oteracilIBA
01/2016
1PotassiumIBA
01/2016
1Gefitinib (Iressa)FDA Link
10/2015
1Docetaxel (Taxotere)FDA Link
10/2015
1Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA
07/2015
1Fluorouracil (Carac)FDA LinkGeneric
01/2012
1AntigensIBA
01/2012
1ProdrugsIBA
01/2012
1Capecitabine (Xeloda)FDA Link
01/2012
1Tumor Biomarkers (Tumor Markers)IBA
01/2012
1Carcinoembryonic AntigenIBA
01/2012
1CarbohydratesIBA
01/2012
1Caffeine (No Doz)FDA LinkGeneric
01/2010
1Tyrosine (L-Tyrosine)FDA Link
05/2009
1atelocollagenIBA
06/2008
1Small Interfering RNA (siRNA)IBA
06/2008
1Biological ProductsIBA
07/2006
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
07/2006
1VaccinesIBA
12/2004
1ParaffinIBA
12/2004
1AntibodiesIBA
12/2004
1Tumor Viral Antigens (Large T Antigen)IBA
12/2004

Therapy/Procedure

7Drug Therapy (Chemotherapy)
04/2021 - 09/2016
4Therapeutics
07/2018 - 06/2008
1Cell Transplantation
10/2020
1Transplantation
10/2020
1Time-to-Treatment
01/2012